Madrid Cancer Diagnostics Company Opens Dallas Office

In August, the company announced it had met the funding requirements for a clinical trial of Signal-C, a DNA test designed to detect colorectal cancer and advanced precancerous lesions.

Founded in 2012 and headquartered in Madrid, Spain, Universal DX boasts an international presence and a multidisciplinary team with extensive experience in cancer research, treatment, and prevention. Leveraging machine learning and advanced technologies, the team is focused on identifying DNA regions linked to various cancer types.

Learn more